Christine M. Peterson
Research Subjects
Christine M. Peterson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Christine O. Menias
Mayo Clinic LL Radiology, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA; Mayo Clinic Hospital, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA
3 shared publicationsAmy K. Hara
1 shared publicationCeline Buckley
1 shared publicationDouglas S. Katz
Department of Radiology, Winthrop-University Hospital, Mineola, NY 11501, USA; State University of New York at Stony Brook, Stony Brook, NY 11794, USA
1 shared publicationJay P. Heiken
1 shared publicationJeffrey W. Carenza
1 shared publication
Latest Publications
- 1 September 2014
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 52 (5) , 1041-1053
Radiation-induced Effects to Nontarget Abdominal and Pelvic Viscera
- 1 September 2014
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 52 (5) , 1041-1053
Radiation-induced Effects to Nontarget Abdominal and Pelvic Viscera
- 1 November 2012
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 41 (6) , 210-219
Teratomas: A Multimodality Review
- 1 November 2012
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 41 (6) , 210-219
Teratomas: A Multimodality Review
- 1 March 2011
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 35 (2) , 202-205
Prospective Randomized Trial of Iohexol 350 Versus Meglumine Sodium Diatrizoate as an Oral Contrast Agent for Abdominopelvic Computed Tomography
To compare the efficacy and patient tolerance of iohexol and meglumine sodium diatrizoate as oral contrast agents for computed tomography (CT). One hundred patients were randomly assigned to drink 1000 mL of either meglumine sodium diatrizoate or iohexol 350 before their abdominopelvic CT examination. The images were evaluated independently and in a blinded fashion by 2 radiologists who scored the extent and density of bowel opacification. Attenuation value measurements were obtained in representative areas of each gastrointestinal tract segment (stomach, duodenum, jejunum, ileum, and colon) by a research technologist. Patients' tolerance of the oral contrast agent was assessed through a questionnaire administered immediately after the CT and with a follow-up phone call 2 to 3 days later. For most of the bowel, there was no statistically significant difference in the extent or degree of opacification between the 2 contrast agents. Opacification of the ileum was better with iohexol. There was no statistically significant difference between the 2 agents in adverse effects. Patients had a small but statistically significant preference for the taste of iohexol. Iohexol 350 is a satisfactory oral contrast agent for abdominopelvic CT. It opacifies the gastrointestinal tract as well as meglumine sodium diatrizoate does, and patients prefer the taste of iohexol to that of diatrizoate.
- 1 March 2011
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 35 (2) , 202-205
Prospective Randomized Trial of Iohexol 350 Versus Meglumine Sodium Diatrizoate as an Oral Contrast Agent for Abdominopelvic Computed Tomography
To compare the efficacy and patient tolerance of iohexol and meglumine sodium diatrizoate as oral contrast agents for computed tomography (CT). One hundred patients were randomly assigned to drink 1000 mL of either meglumine sodium diatrizoate or iohexol 350 before their abdominopelvic CT examination. The images were evaluated independently and in a blinded fashion by 2 radiologists who scored the extent and density of bowel opacification. Attenuation value measurements were obtained in representative areas of each gastrointestinal tract segment (stomach, duodenum, jejunum, ileum, and colon) by a research technologist. Patients' tolerance of the oral contrast agent was assessed through a questionnaire administered immediately after the CT and with a follow-up phone call 2 to 3 days later. For most of the bowel, there was no statistically significant difference in the extent or degree of opacification between the 2 contrast agents. Opacification of the ileum was better with iohexol. There was no statistically significant difference between the 2 agents in adverse effects. Patients had a small but statistically significant preference for the taste of iohexol. Iohexol 350 is a satisfactory oral contrast agent for abdominopelvic CT. It opacifies the gastrointestinal tract as well as meglumine sodium diatrizoate does, and patients prefer the taste of iohexol to that of diatrizoate.
- 1 September 2009
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 29 (5) , 1281-1293
Volvulus of the Gastrointestinal Tract: Appearances at Multimodality Imaging
Volvulus of the gastrointestinal tract, a clinically relevant cause of acute or recurring abdominal pain in adults, remains a diagnostic dilemma for radiologists in a large number of cases. The clinical symptoms associated with volvulus are often nonspecific and include pain and nausea with vomiting. Yet referring clinicians often rely on radiologists to make the diagnosis; volvulus is rarely diagnosed clinically. Radiography, fluoroscopy, and computed tomography are the imaging methods most often used for this purpose. Prompt diagnosis is critical to avoid life-threatening complications such as bowel ischemia and infarction. Thus, it is useful for radiologists to be familiar with the various appearances of volvulus throughout the gastrointestinal tract.
- 1 September 2009
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 29 (5) , 1281-1293
Volvulus of the Gastrointestinal Tract: Appearances at Multimodality Imaging
Volvulus of the gastrointestinal tract, a clinically relevant cause of acute or recurring abdominal pain in adults, remains a diagnostic dilemma for radiologists in a large number of cases. The clinical symptoms associated with volvulus are often nonspecific and include pain and nausea with vomiting. Yet referring clinicians often rely on radiologists to make the diagnosis; volvulus is rarely diagnosed clinically. Radiography, fluoroscopy, and computed tomography are the imaging methods most often used for this purpose. Prompt diagnosis is critical to avoid life-threatening complications such as bowel ischemia and infarction. Thus, it is useful for radiologists to be familiar with the various appearances of volvulus throughout the gastrointestinal tract.